Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can early COVID-19 drugs keep high-risk patients out of the hospital?

NCT ID NCT04356495

First seen May 15, 2026 · Last updated Jun 16, 2026 · Updated 8 times

Summary

This study tested whether giving early treatment to adults with COVID-19 who have risk factors (like age over 60 or high blood pressure) could prevent them from needing oxygen, hospitalization, or dying. About 412 people took part. The goal was to see if these treatments are safe and effective for use at home.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARS-COV2 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Bordeaux university Hospital

    Bordeaux, 33000, France

  • CHRU de Nancy

    Nancy, France

  • CHU de Dijon-Bourgogne

    Dijon, France

  • CHU de Montpellier

    Montpellier, 34295, France

  • CHU de Toulouse

    Toulouse, France

  • CNGE

    Paris, France

  • Groupe hospitalier Paris Saint Joseph

    Paris, 75014, France

Conditions

The condition(s) this trial relates to.

Coronavinae infectious disease COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.